41 related articles for article (PubMed ID: 36150533)
1. Oxymatrine alleviates high-fat diet/streptozotocin-induced non-alcoholic fatty liver disease in C57BL/6 J mice by modulating oxidative stress, inflammation and fibrosis.
Lou D; Fang Q; He Y; Ma R; Wang X; Li H; Qi M
Biomed Pharmacother; 2024 May; 174():116491. PubMed ID: 38537582
[TBL] [Abstract][Full Text] [Related]
2. Yanggan Jiangmei Formula alleviates hepatic inflammation and lipid accumulation in non-alcoholic steatohepatitis by inhibiting the NF-κB/NLRP3 signaling pathway.
Wu Y; Zhou J; Zuo X; Kuang Y; Sun L; Zhang X
Chin J Nat Med; 2024 Mar; 22(3):224-234. PubMed ID: 38553190
[TBL] [Abstract][Full Text] [Related]
3. Pogostone attenuated high-fat diet-induced nonalcoholic fatty liver disease in mice through inhibition of NLRP3 inflammasome signaling.
Tang S; Huang S; Huang J; Lai X; Guo J; Huang J; Zhong Y
Eur J Pharmacol; 2024 May; 970():176463. PubMed ID: 38461909
[TBL] [Abstract][Full Text] [Related]
4. [Overexpression of lncRNA HEM2M alleviates liver injury in mice with non-alcoholic fatty liver disease].
Kong X; Zhang T; Zhang Y; Gao L; Wang W; Wang M; Wang G; Lü K
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):1-8. PubMed ID: 38293970
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Hepatic Steatosis-Intensified Extracellular Vesicle Release to Aggravated Inflammatory Endothelial Injury in Liver-Specific Asah1 Gene Knockout Mice.
Yuan X; Bhat OM; Zou Y; Zhang Y; Li PL
Am J Pathol; 2023 Apr; 193(4):493-508. PubMed ID: 36638912
[TBL] [Abstract][Full Text] [Related]
6. Alpha-lipoic acid alleviates NAFLD and triglyceride accumulation in liver via modulating hepatic NLRP3 inflammasome activation pathway in type 2 diabetic rats.
Ko CY; Lo YM; Xu JH; Chang WC; Huang DW; Wu JS; Yang CH; Huang WC; Shen SC
Food Sci Nutr; 2021 May; 9(5):2733-2742. PubMed ID: 34026086
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Zbtb18 (Zinc Finger and BTB Domain Containing 18) alleviates hepatic steatohepatitis via FXR (Farnesoid X Receptor).
Zhang L; Chen J; Yang X; Shen C; Huang J; Zhang D; Liu N; Liu C; Zhong Y; Chen Y; Tang K; Guo J; Cui T; Duan S; Li J; Huang S; Pan H; Zhang H; Tang X; Chang Y; Gao Y
Signal Transduct Target Ther; 2024 Jan; 9(1):20. PubMed ID: 38263084
[TBL] [Abstract][Full Text] [Related]
8. IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies.
Mirea AM; Tack CJ; Chavakis T; Joosten LAB; Toonen EJM
Trends Mol Med; 2018 May; 24(5):458-471. PubMed ID: 29665983
[TBL] [Abstract][Full Text] [Related]
9. Protective Effects of Iridoid Glycoside from Corni Fructus on Type 2 Diabetes with Nonalcoholic Fatty Liver in Mice.
Niu D; Chen X; Wang T; Wang F; Zhang Q; Xue X; Kang J
Biomed Res Int; 2021; 2021():3642463. PubMed ID: 33542919
[TBL] [Abstract][Full Text] [Related]
10. Trilobatin regulates glucose metabolism by ameliorating oxidative stress and insulin resistance in vivo and in vitro.
He M; Zhang Y; Zhai Y; Li Y; Yang G; Yu S; Xiao H; Song Y
J Pharm Pharmacol; 2024 Apr; ():. PubMed ID: 38642915
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemic and hypolipidemic activities of phlorizin from
Zhang W; Chen S; Fu H; Shu G; Tang H; Zhao X; Chen Y; Huang X; Zhao L; Yin L; Lv C; Lin J
Food Sci Nutr; 2021 Apr; 9(4):1989-1996. PubMed ID: 33841817
[TBL] [Abstract][Full Text] [Related]
12. Penthorum chinense Pursh leaf tea debittering mechanisms via green tea manufacturing process and its influence on NAFLD-alleviation activities.
Tian X; Wang X; Xu W; Gong M; Zhou C; Jiang E; Tang Y; Jia L; Zeng L; Deng S; Duan F
Food Chem; 2024 Jul; 445():138715. PubMed ID: 38382251
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Two Parts of
Wei M; Tuo Y; Zhang Y; Deng Q; Shi C; Chen X; Zhang X
J Anal Methods Chem; 2020; 2020():8837526. PubMed ID: 33163243
[TBL] [Abstract][Full Text] [Related]
14. Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome.
Shen Q; Chen Y; Shi J; Pei C; Chen S; Huang S; Li W; Shi X; Liang J; Hou S
Eur J Pharmacol; 2023 Mar; 942():175504. PubMed ID: 36641101
[TBL] [Abstract][Full Text] [Related]
15. Trilobatin contributes to the improvement of myopathy in a mouse model of Duchenne muscular dystrophy.
Hermes TA; Fratini P; Nascimento BG; Ferreira LL; Petri G; Fonseca FLA; Carvalho AAS; Feder D
Int J Exp Pathol; 2024 Apr; 105(2):75-85. PubMed ID: 38477495
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment.
Qiao O; Wang X; Wang Y; Li N; Gong Y
J Adv Res; 2023 Dec; 54():211-222. PubMed ID: 36702249
[TBL] [Abstract][Full Text] [Related]
17. Dietary Polyphenols as Prospective Natural-Compound Depression Treatment from the Perspective of Intestinal Microbiota Regulation.
Wang X; Yu J; Zhang X
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364464
[TBL] [Abstract][Full Text] [Related]
18. Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation.
Zhang ZT; He WJ; Deng SM; Xu SH; Zeng X; Qian ZM; Chen ZQ; Wang SM; Tang D
Eur J Pharmacol; 2022 Oct; 933():175291. PubMed ID: 36150533
[TBL] [Abstract][Full Text] [Related]
19. Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3.
Ruan S; Han C; Sheng Y; Wang J; Zhou X; Guan Q; Li W; Zhang C; Yang Y
Int Immunopharmacol; 2021 Nov; 100():108126. PubMed ID: 34492534
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
